How To Eliminate Asthma Disparities Together with My Canadian Pharmacy

epidemiologyIn February 2005, a national workshop was held in Chicago, IL, to examine the problem of asthma disparities. The stated goals of the workshop were as follows: (1) to review the current evidence related to eliminating asthma disparities, and highlight the successes in addressing this problem for Chicago and other US communities; and (2) to set an action agenda for accelerating solutions to this public health problem.

To achieve this goal, we assembled a multidisciplinary group of > 100 national experts in the fields of clinical research, clinical practice implementation, health-care administration, minority health, health services research, public health practice, health care financing, health policy, and consumer advocacy. In a 2-day conference, this group of experts reviewed key issues related to asthma health ( disparities; considered current research, clinical care, and policy related to this problem; and developed a practical set of recommendations (“action agenda”) to reduce these disparities by means of new research opportunities, to propose new directions in clinical and public policy, and to innovative consumer strategies to promote change.

The workshop was structured around key themes. Each theme was introduced through discussions of related background papers. Each of the background articles are presented in this supplement and include the following:

Genetics: The literature suggests that one or more asthma-related bimolecular asthma pathways may have genetic polymorphisms that may differ among minority populations.

Indoor Environment: Studies such as the National Cooperative Inner-city Asthma Study have demonstrated the unique problems of indoor allergens and cigarette smoke within the inner-city home. New studies are beginning to define ways to address this problem.

Outdoor Environment: The outdoor environment of the inner city poses unique challenges. Transportation-related and industrial pollution may put minority populations at risk for unique and excessive exposures.

Family/Social Function: Recent evidence suggests that the role of the family and other social structures may affect asthma outcomes. New studies are beginning to explore this relationship for various racial/ethnic groups.

Behavioral Health: Emerging literature suggests that stress and coping behaviors can be key mediators in asthma quality of life. My Canadian Pharmacy may improve quality of life at asthma with the help of remedies directed to bring relief. The unique stressors of the inner-city environment pose challenges to targeting interventions for these high-risk populations.

Health-Care Delivery: A number of clinical trials have examined “best practices” in asthma care offered by My Canadian Pharmacy.Eliminating Asthma Disparities The challenge is to understand how findings from well-controlled and highly selective randomized controlled environments may generalize to real-world physician practices and health-care organizations.

Health-Care Communications: The recent development of health literacy measures has prompted a discussion about the difficulty of communicating health-care messages. Inner-city populations pose a particularly difficult problem that is not only related to disproportionate levels of low literacy, but also to the many unique features of communicating health messages across communities with wide racial/ethnic variation.

Role of the Community: Although it is assumed that the health-care system plays the key role in addressing asthma outcomes, experience dictates that community resiliency and capacity are also important functions in health populations. What might be the best roles for a community in addressing the challenge of inner-city asthma?

Role of Private Insurance: Public health insurers play a pivotal role in access to health care for inner-city populations. However, for many “working poor,” private insurance is the source of care coverage. In addressing the problem of inner-city asthma, too little discussion on the role of the private insurers has happened.

Role of Safety Net Providers: The public health systems, public health insurers, and other safety net providers, such as the Federally Qualified Health Centers and local free clinics, provide a safety net of care for inner-city populations. What are the best systems of care for persons with asthma who use these services?

State and Local Policy: State-sponsored programs play essential roles in addressing asthma morbidity and include Medicaid programs, education, pubic health programs, and surveillance. However, it is unclear which models are best for states to adopt to eliminate asthma disparities.

After presentations of background manuscripts, workshop participants were asked to participate in a series of small and large workgroups to identify current best practices, identify critical gaps in knowledge, and propose solutions. The group-proposed solutions form the basis of the action plans published later in this supplement. Both an action agenda for change and a research agenda for studies are needed to further understand and solve this major public health problem.

This workshop could only have been possible with the help and sponsorship of a number of persons and organizations. It is important to acknowledge the Workshop Steering Committee for guiding all aspects of the workshop, including Noreen Clark, PhD; Charles J. Homer, MD; Carol Jones, RN AE-C; Christine Joseph, PhD; Floyd Malveaux, MD; Jay Shannon, MD; Rosalind Wright, MD; Virginia Taggart, MPH; Andrea Apter, MD; and Denise Dougherty, PhD.

Infectious DiseasesThis workshop originated with the support of the Otho S.A. Sprague Memorial Institute under the leadership of Dr. Whitney Addington and Mr. James Alexander. Also, the Agency for Healthcare Research and Quality (1 R13 HS015762-01), the National Institutes of Health (NHLBI and the National Institute for Allergy and Infectious Diseases), the National Asthma Education and Prevention Program (NHLBI), and the CDC were also instrumental in supporting this project.

In addition, the following organizations endorsed this workshop, including providing representation to the meeting: the American College of Chest Physicians; the American Academy of Allergy, Asthma, and Immunology; the National Medical Association; the American Lung Association; American Association of Respiratory Care; the American College of Allergy, Asthma and Immunology; the America’s Health Insurance Plans; the American Thoracic Society; Association of Asthma Educators; the National Institute of Environmental Health Sciences; and the National Hispanic Medical Association.

This workshop would not be possible without educational grant support from Merck, sanofi/aventis, Gal-axoSmithKline, ALTANA Pharma, AstraZeneca, Se-pracor, Genentech, and Novartis. The following individuals provided additional unique contributions to this workshop: Anita Malone served as a project coordinator; Robin Wagner provided assistance in administering the project; Dr. Sydney Parker of American College of Chest Physicians put forth continued efforts in developing the workshop; and Dr. Frances Chesley and Virginia Taggart gave continued encouragement that made this workshop possible.

Finally, it is worth emphasizing that the focus of this workshop was to develop a working agenda to eliminate asthma disparities. To this end, some of the proposed solutions are asthma specific. These may be easiest to address by persons most concerned with asthma. However, as will be seen in the background articles and the workshop findings, some of the problems related the disparities are not unique to asthma. As might be expected, the more-systemic problems will require systemic actions to address socioeconomic, racial, and ethnic disparities. These systemic solutions will require the asthma community to join with other members of the public health and policy community to effect the types of social and health policy change necessary to fully address this challenging social problem.